Funding for this research was provided by:
National Institute of General Medical Sciences (R01-GM101689)
Received: 1 July 2019
Accepted: 11 October 2019
First Online: 24 October 2019
Compliance with ethical standards
: Drs. Jain and Cleves have a financial interest in BioPharmics LLC, a biotechnology company whose main focus is in the development of methods for computational modeling in drug discovery.